Evidence map›Paper›PMID 21070241›Full record

ArticleJournal of neurochemistry2011

Cold pre-conditioning neuroprotection depends on TNF-α and is enhanced by blockade of interleukin-11.

Heidi M Mitchell, David M White, Miriam S Domowicz, Richard P Kraig

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Resuscitating the Globally Ischemic Brain: TTM and Beyond.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.Cellular and molecular life sciences : CMLS · 2013
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Heidi M MitchellDepartment of Neurology, The University of Chicago Medical Center, Chicago, Illinois 60637, USA.
David M White
Miriam S Domowicz
Richard P Kraig
University of Chicago · USUniversity of Chicago Medical Center · US

Funding

THE MOLECULAR BASIS OF B-MANNOSIDOSISP01HD009402 · NICHD · UNIVERSITY OF CHICAGO · PI KRAIG, RICHARD P · 1985 to 2015
$13.0M
HYDROGEN IONS AND BRAIN INFARCTIONR01NS019108 · NINDS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI KRAIG, RICHARD P · 1985 to 2019
$5.2M
NICHD NIH HHS 5 P01 HD 09402NICHD NIH HHS P01 HD009402NINDS NIH HHS NS-19108NINDS NIH HHS R01 NS019108
6 · The paper itself

Abstract

Cold pre-conditioning reduces subsequent brain injury in small animals but the underlying mechanisms remain undefined. As hypothermia triggers systemic macrophage tumor necrosis factor alpha (TNF-α) production and other neural pre-conditioning stimuli depend on this cytokine, we reasoned that microglia and TNF-α would be similarly involved with cold pre-conditioning neuroprotection. Also, as slice cultures closely approximate their in vivo counterpart and include quiescent microglia, we used rat hippocampal slice cultures to confirm this hypothesis. Furthermore, inflammatory cytokine gene screening with subsequent PCR and immunostaining confirmation of targeted mRNA and related protein changes showed that cold pre-conditioning triggered a significant rise in TNF-α that localized to microglia and a significant rise in interleukin (IL)-11 that localized mainly to hippocampal pyramidal neurons and, more rarely, astrocytes. Importantly, co-stimulation with cold and IL-11, an anti-inflammatory cytokine that inhibits TNF-α expression, abrogated the otherwise evident protection. Instead, cold pre-conditioning coupled with blockade of IL-11 signaling further enhanced neuroprotection from that seen with cold pre-conditioning alone. Thus, physiological activation of brain pro-inflammatory cytokine signaling, and its amplification by inhibition of coincident anti-inflammatory cytokine signaling, may be opportune targets for the development of novel therapeutics that can mimic the protection seen in cold pre-conditioning.

Indexed as

Cold TemperatureAnalysis of VarianceAnimalsAnimals, NewbornAntibodiesCA1 Region, HippocampalCulture Media, Serum-FreeCytokinesExcitatory Amino Acid AgonistsGene Expression RegulationGlial Fibrillary Acidic ProteinInterleukin-11NeuronsNeuroprotective AgentsN-MethylaspartatePhosphopyruvate HydrataseAntibodiesCulture Media, Serum-FreeCytokinesExcitatory Amino Acid AgonistsGlial Fibrillary Acidic ProteinInterleukin-11Neuroprotective AgentsN-MethylaspartatePhosphopyruvate HydrataseReceptors, Tumor Necrosis Factor, Type IRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID21070241
PMCPMC3635118
OpenAlexW1721728417

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.